Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war with Eli Lilly

u/charon-the-boatman · Reddit — r/stocks · January 06, 2026 at 08:38 · ⬆ 410 pts · 💬 86 comments  | View on Reddit ↗
AI Summary

Original Reddit post

The author shares Novo Nordisk's U.S. launch of the oral Wegovy pill as a catalyst and discloses a long position.

NVO — LONG The author holds Novo Nordisk shares and highlights the U.S. launch of the Wegovy Pill as the key catalyst. The pill is priced at $149/month versus roughly $1,000 for injectables, with about 17% weight loss, and wide pharmacy/telehealth availability, positioning Novo to gain market share from Eli Lilly.

Novo Nordisk (NVO) has seen a significant boost in its stock over the last few trading days (in 5 days 11%), primarily driven by the official U.S. launch of the Wegovy Pill.

Score 410
Comments 86
Full Post Text
Ideas
u/charon-the-boatman Reddit r/stocks
Novo's oral Wegovy launch underpriced vs injectables, taking share from Lilly.
The author holds Novo Nordisk shares and highlights the U.S. launch of the Wegovy Pill as the key catalyst. The pill is priced at $149/month versus roughly $1,000 for injectables, with about 17% weight loss, and wide pharmacy/telehealth availability, positioning Novo to gain market share from Eli Lilly.
More from Reddit — r/stocks

This Reddit post, published January 06, 2026, features u/charon-the-boatman discussing NVO. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/charon-the-boatman  · Tickers: NVO